feed,title,long_url,short_url
MedRxiv,SARS-CoV-2 vaccine breakthrough by Omicron and Delta variants: comparative assessments with New York State genomic surveillance data,https://medrxiv.org/cgi/content/short/2022.06.24.22276709v1?rss=1,https://bit.ly/3xTZedP
MedRxiv,Immunogenicity and safety of COVID-19 vaccine in lung cancer patients receiving anticancer treatment: A prospective multicenter cohort study,https://medrxiv.org/cgi/content/short/2022.06.23.22276536v1?rss=1,https://bit.ly/3Opx9SR
MedRxiv,"Efficacy and safety of ensitrelvir in patients with mild-to-moderate COVID-19: the phase 2b part of a randomized, placebo-controlled, phase 2/3 study",https://medrxiv.org/cgi/content/short/2022.06.22.22276792v1?rss=1,https://bit.ly/3HSnNMM
MedRxiv,Inflammasome activation and pulmonary viral loads define two distinct clinical outcomes in COVID-19,https://medrxiv.org/cgi/content/short/2022.06.24.22276878v1?rss=1,https://bit.ly/3HTSjpz
MedRxiv,The mental wellbeing of prison staff in England during the COVID-19 pandemic: a cross-sectional study,https://medrxiv.org/cgi/content/short/2022.06.24.22276867v1?rss=1,https://bit.ly/3HWZfSM
